President Trump is scheduled to deliver remarks from the White House regarding a new initiative aimed at lowering prescription drug costs within the Medicaid program. The administration plans to introduce a "most favored nation" pricing structure, which would allow Medicaid programs in all 50 states, as well as Washington D.C. and Puerto Rico, to access drug prices negotiated by the federal government with pharmaceutical companies.

While the core policy details remain consistent across reports, the framing of the event varies. The Hill positions the announcement as a continuation of the administration's broader efforts to address drug pricing. In contrast, the Washington Examiner provides multiple updates, with one report framing the event as a broader "Medicaid reform" announcement and another focusing specifically on the administration's role in negotiating these lower prices directly with drug manufacturers. The event is expected to feature the participation of several governors in the Oval Office to highlight state-level involvement in the program.